Point72 Biotech Private Investments, Llc - Net Worth and Insider Trading
Point72 Biotech Private Investments, Llc Net Worth
The estimated net worth of Point72 Biotech Private Investments, Llc is at least $899 Million dollars as of 2025-06-09. Point72 Biotech Private Investments, Llc is the of Prometheus Biosciences Inc and owns about 4,496,048 shares of Prometheus Biosciences Inc (RXDX) stock worth over $899 Million. Details can be seen in Point72 Biotech Private Investments, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Point72 Biotech Private Investments, Llc has not made any transactions after 2021-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Point72 Biotech Private Investments, Llc
Point72 Biotech Private Investments, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Point72 Biotech Private Investments, Llc owns 1 companies in total, including Prometheus Biosciences Inc (RXDX) .
Insider Ownership Summary of Point72 Biotech Private Investments, Llc
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2021-03-16 | 10 percent owner |
Point72 Biotech Private Investments, Llc Latest Holdings Summary
Point72 Biotech Private Investments, Llc currently owns a total of 1 stock. Point72 Biotech Private Investments, Llc owns 4,496,048 shares of Prometheus Biosciences Inc (RXDX) as of March 16, 2021, with a value of $899 Million.
Latest Holdings of Point72 Biotech Private Investments, Llc
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2021-03-16 | 4,496,048 | 199.92 | 898,849,916 |
Holding Weightings of Point72 Biotech Private Investments, Llc
Point72 Biotech Private Investments, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Point72 Biotech Private Investments, Llc has made a total of 1 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prometheus Biosciences Inc is the acquisition of 800,000 shares on March 16, 2021, which cost Point72 Biotech Private Investments, Llc around $15 Million.
Insider Trading History of Point72 Biotech Private Investments, Llc
- 1
Point72 Biotech Private Investments, Llc Trading Performance
GuruFocus tracks the stock performance after each of Point72 Biotech Private Investments, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Point72 Biotech Private Investments, Llc is 28.91%. GuruFocus also compares Point72 Biotech Private Investments, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Point72 Biotech Private Investments, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Point72 Biotech Private Investments, Llc's insider trading performs compared to the benchmark.
Performance of Point72 Biotech Private Investments, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13 | | | | | |
| Relative Return to S&P 500(%) | 7.38 | | | | | |
Point72 Biotech Private Investments, Llc Ownership Network
Ownership Network List of Point72 Biotech Private Investments, Llc
Ownership Network Relation of Point72 Biotech Private Investments, Llc
Point72 Biotech Private Investments, Llc Owned Company Details
What does Prometheus Biosciences Inc do?
Who are the key executives at Prometheus Biosciences Inc?
Point72 Biotech Private Investments, Llc is the 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .
Prometheus Biosciences Inc (RXDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prometheus Biosciences Inc Insider Transactions
Point72 Biotech Private Investments, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Point72 Biotech Private Investments, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Point72 Biotech Private Investments, Llc's mailing address is: Stamford Ct 06902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
